The Design of New Adjuvants for Mucosal Immunity to Neisseria meningitidis B in Nasally Primed Neonatal Mice for Adult Immune Response

The aim of this study was to determine the value of detoxified Shiga toxins Stx1 and Stx2 (toxoids of Escherichia coli) as mucosal adjuvants in neonatal mice for immunogenicity against the outer membrane proteins (OMPs) of Neisseria meningitidis B. Mucosal immunization has been shown to be effective...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatiane Ferreira, Elizabeth De Gaspari
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/2012/292073
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552753460674560
author Tatiane Ferreira
Elizabeth De Gaspari
author_facet Tatiane Ferreira
Elizabeth De Gaspari
author_sort Tatiane Ferreira
collection DOAJ
description The aim of this study was to determine the value of detoxified Shiga toxins Stx1 and Stx2 (toxoids of Escherichia coli) as mucosal adjuvants in neonatal mice for immunogenicity against the outer membrane proteins (OMPs) of Neisseria meningitidis B. Mucosal immunization has been shown to be effective for the induction of antigen-specific immune responses in both the systemic and mucosal compartments. Systemic antibody levels (IgG, IgG1, IgG2a, IgG2b, IgM, and IgA) and mucosal IgM and IgA were measured by ELISA using an N. meningitidis as an antigen. In addition, IFN-γ and IL-6 production were measured after stimulated proliferation of immune cells. Intranasal administration elicited a higher anti-OMP IgA response in both saliva and vaginal fluids. Our results suggest that both Stx1 and Stx2 toxoids are effective mucosal adjuvants for the induction of Ag-specific IgG, IgM, and IgA antibodies. The toxoids significantly enhanced the IgG and IgM response against OMPs with a potency equivalent to CT, with the response being characterized by both IgG1 and IgG2a isotypes, and increased IFN-gamma production. Additionally, bactericidal activity was induced with IgG and IgM antibodies of high avidity. These results support the use of the new toxoids as potent inducing adjuvants that are particularly suitable for mucosal immunization.
format Article
id doaj-art-09756182309643dfb5b5846fc42af823
institution Kabale University
issn 1537-744X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-09756182309643dfb5b5846fc42af8232025-02-03T05:57:49ZengWileyThe Scientific World Journal1537-744X2012-01-01201210.1100/2012/292073292073The Design of New Adjuvants for Mucosal Immunity to Neisseria meningitidis B in Nasally Primed Neonatal Mice for Adult Immune ResponseTatiane Ferreira0Elizabeth De Gaspari1Immunology Department, Adolfo Lutz Institute, Avenue Dr. Arnaldo 355, 11 andar, 01246-902 São Paulo, SP, BrazilImmunology Department, Adolfo Lutz Institute, Avenue Dr. Arnaldo 355, 11 andar, 01246-902 São Paulo, SP, BrazilThe aim of this study was to determine the value of detoxified Shiga toxins Stx1 and Stx2 (toxoids of Escherichia coli) as mucosal adjuvants in neonatal mice for immunogenicity against the outer membrane proteins (OMPs) of Neisseria meningitidis B. Mucosal immunization has been shown to be effective for the induction of antigen-specific immune responses in both the systemic and mucosal compartments. Systemic antibody levels (IgG, IgG1, IgG2a, IgG2b, IgM, and IgA) and mucosal IgM and IgA were measured by ELISA using an N. meningitidis as an antigen. In addition, IFN-γ and IL-6 production were measured after stimulated proliferation of immune cells. Intranasal administration elicited a higher anti-OMP IgA response in both saliva and vaginal fluids. Our results suggest that both Stx1 and Stx2 toxoids are effective mucosal adjuvants for the induction of Ag-specific IgG, IgM, and IgA antibodies. The toxoids significantly enhanced the IgG and IgM response against OMPs with a potency equivalent to CT, with the response being characterized by both IgG1 and IgG2a isotypes, and increased IFN-gamma production. Additionally, bactericidal activity was induced with IgG and IgM antibodies of high avidity. These results support the use of the new toxoids as potent inducing adjuvants that are particularly suitable for mucosal immunization.http://dx.doi.org/10.1100/2012/292073
spellingShingle Tatiane Ferreira
Elizabeth De Gaspari
The Design of New Adjuvants for Mucosal Immunity to Neisseria meningitidis B in Nasally Primed Neonatal Mice for Adult Immune Response
The Scientific World Journal
title The Design of New Adjuvants for Mucosal Immunity to Neisseria meningitidis B in Nasally Primed Neonatal Mice for Adult Immune Response
title_full The Design of New Adjuvants for Mucosal Immunity to Neisseria meningitidis B in Nasally Primed Neonatal Mice for Adult Immune Response
title_fullStr The Design of New Adjuvants for Mucosal Immunity to Neisseria meningitidis B in Nasally Primed Neonatal Mice for Adult Immune Response
title_full_unstemmed The Design of New Adjuvants for Mucosal Immunity to Neisseria meningitidis B in Nasally Primed Neonatal Mice for Adult Immune Response
title_short The Design of New Adjuvants for Mucosal Immunity to Neisseria meningitidis B in Nasally Primed Neonatal Mice for Adult Immune Response
title_sort design of new adjuvants for mucosal immunity to neisseria meningitidis b in nasally primed neonatal mice for adult immune response
url http://dx.doi.org/10.1100/2012/292073
work_keys_str_mv AT tatianeferreira thedesignofnewadjuvantsformucosalimmunitytoneisseriameningitidisbinnasallyprimedneonatalmiceforadultimmuneresponse
AT elizabethdegaspari thedesignofnewadjuvantsformucosalimmunitytoneisseriameningitidisbinnasallyprimedneonatalmiceforadultimmuneresponse
AT tatianeferreira designofnewadjuvantsformucosalimmunitytoneisseriameningitidisbinnasallyprimedneonatalmiceforadultimmuneresponse
AT elizabethdegaspari designofnewadjuvantsformucosalimmunitytoneisseriameningitidisbinnasallyprimedneonatalmiceforadultimmuneresponse